Poland’s biopharmaceutical innovation creates ‘win-win’ game for economy, patients on 24/10/23
Natalizumab, the world's first biosimilar drug for multiple sclerosis, produced in Poland, has been approved by the European Medicines Agency (EMA), adding to the biosimilar legacy that Warsaw seems to be building in the hope of improving the Polish economy, but also patients’ lives across Europe. Sale of antibiotics in Bulgaria fell with digital prescriptions on 24/10/23
The sale of antibiotics in Bulgaria fell sharply by nearly 35% immediately after the introduction of digital prescriptions, which led to greater control over the sale of these drugs, Deputy Minister of Health, Ilko Getov, said. Dutch cancer medication spending doubles over ten years on 24/10/23
With expenditure on cancer medication in the Netherlands reaching record levels, organisations are calling for more research to ensure the drugs are used sustainably and for EU member states to keep pace with established plans to ensure their citizens don’t get left behind. Triage chatbot for patients under scrutiny in Sweden on 24/10/23
Following a report showing that one in five patients received the wrong medical priority, the Swedish Medical Products Agency is investigating a chatbot that triages people seeking healthcare advice across the country. Czech oncology boasts screening programs but lacks affordable medicines on 23/10/23
Contrary to other EU countries, the Czech Republic is succeeding in the implementation of screening programmes in the fight against cancer, but Prague is still facing a scarcity of availability of innovative drugs. Netherlands identifies 11 health conditions with possible gaps in drug development on 23/10/23
The Netherlands has identified 11 medical conditions, including anxiety, stroke, and breast cancer, with a possible gap in developing drugs, according to a report commissioned by the government which called for better collaboration between the industry and academia. New rules lowering asbestos exposure limits adopted on 23/10/23
The EU Council on Monday (23 October) formally adopted the directive to step up the protection of workers from health risks related to asbestos, the final stage in the legislative process for the file. Sweden’s snus EU future still uncertain amid tobacco directive evaluation on 23/10/23
The future of Sweden’s snus, a moist oral tobacco product currently banned in the EU, will be decided based on the ongoing evaluation of the tobacco directive, a European Commission spokesperson told Euractiv. Snus has been banned in the EU... Europe’s healthcare ambitions: right diagnosis, wrong treatment [Promoted content] on 23/10/23
In my role I look at a lot of dashboards, like the one I read perhaps daily showing whether patients across Europe are able to access a new treatment following its approval by the European Medicines Agency (EMA), the medicine regulator. EU countries criticised for patching up healthcare gaps through migration on 19/10/23
EU countries recruiting foreign healthcare staff to address shortages, rather than investing in domestic workforce development, may weaken the EU's international health cooperation efforts, an EU Commission official warned.
|
|
